1. Home
  2. EDBL vs CRIS Comparison

EDBL vs CRIS Comparison

Compare EDBL & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edible Garden AG Incorporated

EDBL

Edible Garden AG Incorporated

HOLD

Current Price

$1.19

Market Cap

2.8M

ML Signal

HOLD

Logo Curis Inc.

CRIS

Curis Inc.

HOLD

Current Price

$0.87

Market Cap

2.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDBL
CRIS
Founded
2020
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
2.3M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
EDBL
CRIS
Price
$1.19
$0.87
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
★ 223.7K
132.7K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 91.57
EPS
N/A
★ N/A
Revenue
★ $12,810,000.00
$9,898,000.00
Revenue This Year
$68.17
$27.10
Revenue Next Year
N/A
$67.74
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 31.50
52 Week Low
$0.08
$0.18
52 Week High
$8.60
$6.74

Technical Indicators

Market Signals
Indicator
EDBL
CRIS
Relative Strength Index (RSI) 30.05 19.52
Support Level $0.88 $0.80
Resistance Level $1.22 $1.04
Average True Range (ATR) 0.09 0.11
MACD -0.01 0.05
Stochastic Oscillator 15.56 3.64

Price Performance

Historical Comparison
EDBL
CRIS

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces. Company provides two principal product segments: (i) fresh produce, including cut herbs, hydroponic basil, potted herbs, and wheatgrass; and (ii) shelf-stable and refrigerated consumer packaged goods, including sports nutrition and nutraceuticals.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: